CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 129,349	$ 174,243
Restricted cash	9,375	10,552
Accounts receivable, net of allowance of $41,387 and $50,406 as of September 30, 2019 and December 31, 2018, respectively	426,579	465,264
Contract assets	65,515	66,451
Prepaid expenses and other current assets	142,843	142,455
Total current assets	773,661	858,965
Fixed assets, net	96,813	121,913
Software development costs, net	236,551	209,660
Intangible assets, net	397,950	431,081
Goodwill	1,387,088	1,373,744
Deferred taxes, net	5,049	5,036
Contract assets - long-term	101,920	71,879
Right-of-use assets - operating leases	103,537	0
Other assets	127,372	109,206
Total assets	3,229,941	3,181,484
Current liabilities:
Accounts payable	101,725	73,166
Accrued expenses	261,905	107,068
Accrued compensation and benefits	57,553	100,076
Income tax payable	0	29,644
Deferred revenue	373,105	466,797
Current maturities of long-term debt	358,574	20,059
Current operating lease liabilities	24,451	0
Current liabilities attributable to discontinued operations	0	920
Total current liabilities	1,177,313	797,730
Long-term debt	554,864	647,539
Deferred revenue	12,117	15,984
Deferred taxes, net	55,290	58,470
Long-term operating lease liabilities	100,230	0
Other liabilities	49,069	81,334
Total liabilities	1,948,883	1,601,057
Commitments and contingencies
Stockholders’ equity:
Preferred stock: $0.01 par value, 1,000 shares authorized, no shares issued and outstanding as of September 30, 2019 and December 31, 2018	0	0
Common stock: $0.01 par value, 349,000 shares authorized as of September 30, 2019 and December 31, 2018; 272,496 and 163,219 shares issued and outstanding as of September 30, 2019, respectively; 270,955 and 171,224 shares issued and outstanding as of December 31, 2018, respectively	2,724	2,709
Treasury stock: at cost, 109,277 and 99,731 shares as of September 30, 2019 and December 31, 2018, respectively	(561,857)	(460,543)
Additional paid-in capital	1,876,078	1,881,494
(Accumulated deficit) retained earnings	(30,366)	132,842
Accumulated other comprehensive loss	(5,521)	(5,389)
Total Allscripts Healthcare Solutions, Inc.'s stockholders' equity	1,281,058	1,551,113
Non-controlling interest	0	29,314
Total stockholders’ equity	1,281,058	1,580,427
Total liabilities and stockholders’ equity	$ 3,229,941	$ 3,181,484